Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Juana Oramas Rodríguez"'
Autor:
Esteban Porrini, Nuria Montero, Juan Manuel Díaz, Ricardo Lauzurrica, Juana Oramas Rodríguez, Irene Silva Torres, Francesc Moreso, Josep M Cruzado, Rocío Benítez Ruiz, Meritxel Ibernon Vilaró, Maria Xixiang Molina Lima, Simran Khemlani Ramchand, Juan Carlos Ruiz, Francisco Gainza de los Rios, Carla Rodríguez Alvarez, María del Carmen de Gracia Guindo, Manuel Macías, David Bonet Vela, Antonio Osuna, Beatriz Bayés-Genís, Cristina Aleman Sanchez, María del Carmen Ruiz, Ana Elena Rodríguez Rodríguez, Rosa Domínguez Rollán, Federico González Rinne, Alejandro Jiménez Sosa, Patricia Delgado Mallén, Ana González Rinne, Domingo Marrero Miranda, Armando Torres
Publikováno v:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
Background Diabetes is a risk factor for cancer in the general population. However, few data are available on the association between post-transplant diabetes mellitus (PTDM) and cancer after transplantation. Methods We analyzed this issue in a Spani
Autor:
Jonathan González García, Fernando Gutiérrez Nicolás, Gloria Julia Nazco Casariego, Cristina Valcárcel Nazco, Jose Norberto Batista López, Juana Oramas Rodríguez
Publikováno v:
Farmacia Hospitalaria, Vol 41, Iss 1, Pp 3-13 (2017)
Introduction: Lung cancer is the third most frequent neoplastic tumour in Spain, with around 27 000 new cases diagnosed per year; 80-95% of these are non-small-cell cancer (NSCLC), and the majority of cases are diagnosed in advanced stages of the dis
Autor:
Jonathan, González García, Fernando, Gutiérrez Nicolás, Gloria Julia, Nazco Casariego, Cristina, Valcárcel Nazco, Jose Norberto, Batista López, Juana, Oramas Rodríguez
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 41(n01)
Lung cancer is the third most frequent neoplastic tumour in Spain, with around 27 000 new cases diagnosed per year; 80-95% of these are non-small-cell cancer (NSCLC), and the majority of cases are diagnosed in advanced stages of the disease, and for